Ann: CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial, page-13

Any of the more technically minded holders care to enlighten me on how CYP would potentially be more effective than PAR's Zilusol for OA?

They are already looking at P3, received a stellar peer review Oct 1 and trials on American NFL players should commence next week (former AFL players speak extremely highly of the treatment as do a number of trial patients on the PAR thread). CYP seem a long way behind the game here and I am curious what the big brains see as potential upside in the long term.

Disclosure...i hold both CYP and PAR (and suffer from OA in the knee).